# Lineage Achieves First Milestone Under Worldwide Collaboration Agreement with Genentech
Canonical URL: https://biopharmsignal.com/news/LCTX/lineage-achieves-first-milestone-under-worldwide-collaboration-agreement-with-genentech
Ticker: LCTX
Company: Lineage Cell Therapeutics
Source: Lineage Cell Therapeutics
Published: 2025-11-24 16:20 EST
Original Source URL: https://investor.lineagecell.com
## Summary

LINEAGE ACHIEVES FIRST MILESTONE UNDER WORLDWIDE COLLABORATION AGREEMENT WITH GENENTECH  November 24, 2025 Lineage Cell Therapeutics, Inc.  today announced it had achieved the first milestone available under its worldwide  collaboration with  Roche  and  Genentech , a member of the Roche G

## Article Body
LINEAGE ACHIEVES FIRST MILESTONE UNDER WORLDWIDE COLLABORATION AGREEMENT WITH GENENTECH  November 24, 2025 Lineage Cell Therapeutics, Inc.  today announced it had achieved the first milestone available under its worldwide  collaboration with  Roche  and  Genentech , a member of the Roche Group, for
## Recent Company News
- 2026-05-12 20:01 EST — [Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/LCTX/lineage-cell-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update) — Source: Lineage Cell Therapeutics
- 2026-05-05 12:00 EST — [Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026](https://biopharmsignal.com/news/LCTX/lineage-cell-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-12-2026) — Source: Lineage Cell Therapeutics
- 2026-05-04 12:00 EST — [OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026](https://biopharmsignal.com/news/LCTX/opregenr-3-year-results-in-patients-with-ga-presented-at-foundation-fighting-blindness-retinal-innovation-summit-2026) — Source: Lineage Cell Therapeutics
- 2026-04-13 12:00 EST — [Lineage Announces Formation of Scientific Advisory Board](https://biopharmsignal.com/news/LCTX/lineage-announces-formation-of-scientific-advisory-board) — Source: Lineage Cell Therapeutics
- 2026-03-24 12:00 EST — [Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease](https://biopharmsignal.com/news/LCTX/lineage-launches-new-cell-therapy-program-in-corneal-endothelial-disease) — Source: Lineage Cell Therapeutics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)